IOVANCE BIOTHERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Iovance Biotherapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -65 %, a 17% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Return On Equity for 2023 was -70.9 %, a 14.1% increase from 2022.
  • Iovance Biotherapeutics, Inc. annual Return On Equity for 2022 was -82.6 %, a 63.5% decline from 2021.
  • Iovance Biotherapeutics, Inc. annual Return On Equity for 2021 was -50.5 %, a 15.2% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -70.9 +11.6 +14.1% Jan 1, 2023 Dec 31, 2023
2022 -82.6 -32.1 -63.5% Jan 1, 2022 Dec 31, 2022
2021 -50.5 -6.67 -15.2% Jan 1, 2021 Dec 31, 2021
2020 -43.8 +9.35 +17.6% Jan 1, 2020 Dec 31, 2020
2019 -53.2 -14.7 -38% Jan 1, 2019 Dec 31, 2019
2018 -38.5 +23.9 +38.3% Jan 1, 2018 Dec 31, 2018
2017 -62.4 -29 -87% Jan 1, 2017 Dec 31, 2017
2016 -33.4 -8.11 -32.1% Jan 1, 2016 Dec 31, 2016
2015 -25.3 +25.3 +50% Jan 1, 2015 Dec 31, 2015
2014 -50.6 -12.9K -100% Jan 1, 2014 Dec 31, 2014
2013 12.9K +12.9K +60107% Jan 1, 2013 Dec 31, 2013
2012 21.4 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.